{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T15:32:38Z","timestamp":1782228758240,"version":"3.54.5"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2019,7,4]],"date-time":"2019-07-04T00:00:00Z","timestamp":1562198400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,7,4]],"date-time":"2019-07-04T00:00:00Z","timestamp":1562198400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Roche Diagnostics International Ltd"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Endocrinol Invest"],"published-print":{"date-parts":[[2019,11]]},"DOI":"10.1007\/s40618-019-01075-w","type":"journal-article","created":{"date-parts":[[2019,7,4]],"date-time":"2019-07-04T16:03:45Z","timestamp":1562256225000},"page":"1353-1360","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["Parathyroid hormone reference ranges in healthy individuals classified by vitamin D status"],"prefix":"10.1007","volume":"42","author":[{"given":"N.","family":"Yalla","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Bobba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Stankiewicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Ostlund","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,7,4]]},"reference":[{"key":"1075_CR1","doi-asserted-by":"publisher","first-page":"2922","DOI":"10.1210\/jc.2013-1294","volume":"98","author":"M Metzger","year":"2013","unstructured":"Metzger M, Houillier P, Gauci C et al (2013) Relation between circulating levels of 25(OH) vitamin D and parathyroid hormone in chronic kidney disease: quest for a threshold. J Clin Endocrinol Metab 98:2922\u20132928","journal-title":"J Clin Endocrinol Metab"},{"key":"1075_CR2","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1002\/cphy.c140071","volume":"6","author":"SJ Khundmiri","year":"2016","unstructured":"Khundmiri SJ, Murray RD, Lederer E (2016) PTH and vitamin D. Compr Physiol 6:561\u2013601","journal-title":"Compr Physiol"},{"key":"1075_CR3","first-page":"S1","volume":"113","author":"Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Work Group","year":"2009","unstructured":"Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Work Group (2009) KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease\u2014mineral and bone disorder (CKD-MBD). Kidney Int Suppl 113:S1\u2013S130","journal-title":"Kidney Int Suppl"},{"issue":"4 Suppl 3","key":"1075_CR4","first-page":"S1","volume":"42","author":"National Kidney Foundation","year":"2003","unstructured":"National Kidney Foundation (2003) K\/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease. Am J Kidney Dis 42(4 Suppl 3):S1\u2013S201","journal-title":"Am J Kidney Dis"},{"key":"1075_CR5","doi-asserted-by":"publisher","first-page":"107","DOI":"10.11005\/jbm.2015.22.3.107","volume":"22","author":"JH Lee","year":"2015","unstructured":"Lee JH, Choi J-H, Kweon OJ, Park AJ (2015) Discrepancy between vitamin D total immunoassays due to various cross-reactivities. J Bone Metab 22:107\u2013112","journal-title":"J Bone Metab"},{"key":"1075_CR6","doi-asserted-by":"publisher","first-page":"1950","DOI":"10.1093\/ndt\/gfr535","volume":"27","author":"E Cavalier","year":"2012","unstructured":"Cavalier E, Delanaye P, Vranken L et al (2012) Interpretation of serum PTH concentrations with different kits in dialysis patients according to the KDIGO guidelines: importance of the reference (normal) values. Nephrol Dial Transplant 27:1950\u20131956","journal-title":"Nephrol Dial Transplant"},{"key":"1075_CR7","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.nutres.2010.12.001","volume":"31","author":"KY Forrest","year":"2011","unstructured":"Forrest KY, Stuhldreher WL (2011) Prevalence and correlates of vitamin D deficiency in US adults. Nutr Res 31:48\u201354","journal-title":"Nutr Res"},{"key":"1075_CR8","doi-asserted-by":"publisher","first-page":"3570","DOI":"10.1210\/jc.2014-1414","volume":"99","author":"R Eastell","year":"2014","unstructured":"Eastell R, Brandi ML, Costa AG, D\u2019Amour P, Shoback DM, Thakker RV (2014) Diagnosis of asymptomatic primary hyperparathyroidism: proceedings of the fourth international workshop. J Clin Endocrinol Metab 99:3570\u20133579","journal-title":"J Clin Endocrinol Metab"},{"key":"1075_CR9","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1007\/s40618-016-0553-2","volume":"40","author":"JC Souberbielle","year":"2017","unstructured":"Souberbielle JC, Brazier F, Piketty ML, Cormier C, Minisola S, Cavalier E (2017) How the reference values for serum parathyroid hormone concentration are (or should be) established? J Endocrinol Investig 40:241\u2013256","journal-title":"J Endocrinol Investig"},{"key":"1075_CR10","doi-asserted-by":"publisher","first-page":"3501","DOI":"10.1210\/jc.2003-030097","volume":"88","author":"JC Souberbielle","year":"2003","unstructured":"Souberbielle JC, Lawson-Body E, Hammadi B, Sarfati E, Kahan A, Cormier C (2003) The use in clinical practice of parathyroid hormone normative values established in vitamin D-sufficient subjects. J Clin Endocrinol Metab 88:3501\u20133504","journal-title":"J Clin Endocrinol Metab"},{"key":"1075_CR11","doi-asserted-by":"publisher","first-page":"1771","DOI":"10.1373\/clinchem.2006.071589","volume":"52","author":"T Cantor","year":"2006","unstructured":"Cantor T, Yang Z, Caraiani N, Ilamathi E (2006) Lack of comparability of intact parathyroid hormone measurements among commercial assays for end-stage renal disease patients: implication for treatment decisions. Clin Chem 52:1771\u20131776","journal-title":"Clin Chem"},{"key":"1075_CR12","volume-title":"Elecsys vitamin D total II package insert","author":"Roche Diagnostics GmbH","year":"2018","unstructured":"Roche Diagnostics GmbH (2018) Elecsys vitamin D total II package insert. Roche, Mannheim"},{"key":"1075_CR13","volume-title":"Elecsys PTH package insert","author":"Roche Diagnostics GmbH","year":"2014","unstructured":"Roche Diagnostics GmbH (2014) Elecsys PTH package insert. Roche, Mannheim"},{"issue":"Suppl 243","key":"1075_CR14","first-page":"32","volume":"72","author":"CT Sempos","year":"2012","unstructured":"Sempos CT, Vesper HW, Phinney KW et al (2012) The vitamin D standardisation program (VDSP). Vitamin D status as an international issue: national surveys and the problem of standardisation. Scand J Clin Lab Investig 72(Suppl 243):32\u201340","journal-title":"Scand J Clin Lab Investig"},{"issue":"Suppl 243","key":"1075_CR15","first-page":"41","volume":"72","author":"LM Thienpont","year":"2012","unstructured":"Thienpont LM, Stepman HCM, Vesper HW (2012) Standardisation of measurements of 25-hydroxyvitamin D3 and D2. Scand J Clin Lab Investig 72(Suppl 243):41\u201349","journal-title":"Scand J Clin Lab Investig"},{"key":"1075_CR16","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1093\/ajcn\/88.2.511S","volume":"88","author":"KW Phinney","year":"2008","unstructured":"Phinney KW (2008) Development of a standard reference material for vitamin D in serum. Am J Clin Nutr 88:511\u2013512","journal-title":"Am J Clin Nutr"},{"key":"1075_CR17","unstructured":"Clinical and Laboratory Standards Institute (CLSI) (2010) Defining, establishing, and verifying reference intervals in the clinical laboratory; approved guideline, 3rd edn. Document EP28-A3c. CLSI, Wayne"},{"key":"1075_CR18","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.4158\/EP.16.6.1016","volume":"16","author":"NB Watts","year":"2010","unstructured":"Watts NB, Bilezikian JP, Camacho PM et al (2010) American Association of Clinical Endocrinologists Medical Guidelines for Clinical Practice for the diagnosis and treatment of postmenopausal osteoporosis: executive summary of recommendations. Endocr Pract 16:1016\u20131019","journal-title":"Endocr Pract"},{"key":"1075_CR19","doi-asserted-by":"publisher","first-page":"1911","DOI":"10.1210\/jc.2011-0385","volume":"96","author":"MF Holick","year":"2011","unstructured":"Holick MF, Binkley NC, Bischoff-Ferrari HA et al (2011) Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 96:1911\u20131930","journal-title":"J Clin Endocrinol Metab"},{"key":"1075_CR20","doi-asserted-by":"publisher","first-page":"1196","DOI":"10.1210\/jc.2013-3349","volume":"99","author":"M Touvier","year":"2014","unstructured":"Touvier M, Deschasaux M, Montourcy M et al (2014) Interpretation of plasma PTH concentrations according to 25OHD status, gender, age, weight status, and calcium intake: importance of the reference values. J Clin Endocrinol Metab 99:1196\u20131203","journal-title":"J Clin Endocrinol Metab"},{"key":"1075_CR21","doi-asserted-by":"publisher","first-page":"2195","DOI":"10.1373\/clinchem.2004.040683","volume":"50","author":"GD Carter","year":"2004","unstructured":"Carter GD, Carter R, Jones J, Berry J (2004) How accurate are assays for 25-hydroxyvitamin D? Data from the international vitamin D external quality assessment scheme. Clin Chem 50:2195\u20132197","journal-title":"Clin Chem"},{"key":"1075_CR22","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1111\/j.1365-2265.2010.03894.x","volume":"74","author":"L Rejnmark","year":"2011","unstructured":"Rejnmark L, Vestergaard P, Heickendorff L, Mosekilde L (2011) Determinants of plasma PTH and their implication for defining a reference interval. Clin Endocrinol (Oxf) 74:37\u201343","journal-title":"Clin Endocrinol (Oxf)"},{"key":"1075_CR23","doi-asserted-by":"publisher","first-page":"1745","DOI":"10.1007\/s00198-010-1383-2","volume":"22","author":"OM Guti\u00e9rrez","year":"2011","unstructured":"Guti\u00e9rrez OM, Farwell WR, Kermah D, Taylor EN (2011) Racial differences in the relationship between vitamin D, bone mineral density, and parathyroid hormone in the National Health and Nutrition Examination Survey. Osteoporos Int 22:1745\u20131753","journal-title":"Osteoporos Int"},{"key":"1075_CR24","doi-asserted-by":"publisher","first-page":"137","DOI":"10.4158\/EP.12.2.137","volume":"12","author":"JF Aloia","year":"2006","unstructured":"Aloia JF, Feuerman M, Yeh JK (2006) Reference range for serum parathyroid hormone. Endocr Pract 12:137\u2013144","journal-title":"Endocr Pract"},{"key":"1075_CR25","doi-asserted-by":"publisher","first-page":"2066","DOI":"10.1359\/jbmr.2001.16.11.2066","volume":"16","author":"CJ Lamberg-Allardt","year":"2001","unstructured":"Lamberg-Allardt CJ, Outila TA, Karkkainen MU, Rita HJ, Valsta LM (2001) Vitamin D deficiency and bone health in healthy adults in Finland: could this be a concern in other parts of Europe? J Bone Miner Res 16:2066\u20132073","journal-title":"J Bone Miner Res"},{"key":"1075_CR26","unstructured":"United Health Foundation (2007) America\u2019s health rankings: annual report 2017. \n                    https:\/\/www.americashealthrankings.org\/learn\/reports\/2017-annual-report\n                    \n                  . Accessed 9 Nov 2018"},{"key":"1075_CR27","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1530\/EJE-15-0595","volume":"174","author":"JC Souberbielle","year":"2016","unstructured":"Souberbielle JC, Massart C, Brailly-Tabard S et al (2016) Serum PTH reference values established by an automated third-generation assay in vitamin D-replete subjects with normal renal function: consequences of diagnosing primary hyperparathyroidism and the classification of dialysis patients. Eur J Endocrinol 174:315\u2013323","journal-title":"Eur J Endocrinol"},{"key":"1075_CR28","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/j.bone.2009.04.237","volume":"45","author":"L Yan","year":"2009","unstructured":"Yan L, Schoenmakers I, Zhou B et al (2009) Ethnic differences in parathyroid hormone secretion and mineral metabolism in response to oral phosphate administration. Bone 45:238\u2013245","journal-title":"Bone"},{"key":"1075_CR29","doi-asserted-by":"publisher","first-page":"e298","DOI":"10.1515\/cclm-2018-0406","volume":"56","author":"MC Batista","year":"2018","unstructured":"Batista MC, Menegat FD, Ferreira CES, Faulhaber ACL, Campos DALS, Mangueira CLP (2018) Analytical and clinical validation of the new Roche Elecsys Vitamin D Total II assay. Clin Chem Lab Med 56:e298\u2013e301","journal-title":"Clin Chem Lab Med"},{"key":"1075_CR30","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.jsbmb.2017.07.018","volume":"177","author":"GD Carter","year":"2018","unstructured":"Carter GD, Berry J, Durazo-Arvizu R et al (2018) Hydroxyvitamin D assays: an historical perspective from DEQAS. J Steroid Biochem Mol Biol 177:30\u201335","journal-title":"J Steroid Biochem Mol Biol"},{"key":"1075_CR31","unstructured":"Centers for Disease Control and Prevention. CDC vitamin D standardisation-certification program (CDC VDSCP): certified total 25-hydroxyvitamin D procedures. \n                    https:\/\/www.cdc.gov\/labstandards\/pdf\/hs\/CDC_Certified_Vitamin_D_Procedures-508.pdf\n                    \n                  . Accessed 5 Sep 2018"},{"issue":"Suppl","key":"1075_CR32","first-page":"S309","volume":"55","author":"O Broders","year":"2017","unstructured":"Broders O, Engel A, Gerg M, Josel H-P, Vogl C (2017) Locking up 24,25-dihydroxyvitamin D: a new assay for 25-hydroxyvitamin D with improved specificity. Clin Chem Lab Med 55(Suppl):S309","journal-title":"Clin Chem Lab Med"},{"key":"1075_CR33","first-page":"131","volume":"48","author":"D Hermsen","year":"2002","unstructured":"Hermsen D, Franzson L, Hoffmann JP et al (2002) Multicenter evaluation of a new immunoassay for intact PTH measurement on the Elecsys System 2010 and 1010. Clin Lab 48:131\u2013141","journal-title":"Clin Lab"}],"container-title":["Journal of Endocrinological Investigation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-019-01075-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40618-019-01075-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-019-01075-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,2]],"date-time":"2020-07-02T23:05:42Z","timestamp":1593731142000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40618-019-01075-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7,4]]},"references-count":33,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2019,11]]}},"alternative-id":["1075"],"URL":"https:\/\/doi.org\/10.1007\/s40618-019-01075-w","relation":{},"ISSN":["1720-8386"],"issn-type":[{"value":"1720-8386","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,7,4]]},"assertion":[{"value":"20 December 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 June 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 July 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Richard Ostlund has received research support from Roche Diagnostics and Regeneron. Gabriella Bobba, Ge Guo, and Ann Stankiewicz are employees of Roche Diagnostics. Naga Yalla has no conflicts of interest to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. Institutional review board approval was obtained from all participating sites prior to study initiation.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}